-

Thermo Fisher Scientific Opens Its First Electron Microscopy Demo Center in Taiwan

New facility designed to support semiconductor innovation and materials R&D in one of the world’s leading technology hubs

HILLSBORO, Ore.--(BUSINESS WIRE)--To support next-generation semiconductor and materials innovation, Thermo Fisher Scientific today announced the opening of its first electron microscopy demo center in Taiwan. This state-of-the-art facility, called a NanoPort, is strategically located in the region’s semiconductor manufacturing hub and designed to meet the area’s growing need for advanced analytical instruments and expertise. The new center is now one of six Thermo Fisher NanoPort facilities worldwide and will partner with semiconductor customers in the region.

A grand opening and ribbon-cutting ceremony will be held on July 26 featuring local dignitaries and business leaders as esteemed guest speakers.

Demand for higher-performing semiconductor technology is accelerating as innovations such as generative AI, smarter devices, and renewable energy take hold. Similarly, cutting-edge materials research and development projects are accelerating to meet the demand for new and higher-performing materials in applications across new battery development and clean energy, aerospace, automotive, and healthcare, to name a few.

The new NanoPort will provide customers access to Thermo Fisher electron microscopy experts and Thermo Fisher’s latest technologies for materials analysis, process control and quality assurance. Such accessibility is designed to support fundamental research efforts and offer hands-on experiences to help customers learn new ways to reduce time-to-market and ultimately increase profitability.

“Thermo Fisher’s new NanoPort in Taiwan underscores our continuous commitment to the advancement of science and technology worldwide,” said Sho-Wen Yeo, vice president and general manager, Southeast Asia and Taiwan, Thermo Fisher Scientific. “By bringing Thermo Fisher’s world-class analytical instrumentation and expertise to the semiconductor hotspot that is Taiwan, we aim to serve as the go-to R&D partner in the region and enable our customers to propel the innovations that shape our everyday lives.”

Thermo Fisher’s NanoPorts are located worldwide, offering demonstration, testing, and training of Thermo Fisher’s latest electron microscopy technology for those in semiconductor, materials and life sciences. To learn more, please visit: https://ter.li/6dcr07

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

Contacts

Media:
Alex Runner
Thermo Fisher Scientific
alex.runner@thermofisher.com

Jessika Parry, Greenough
419-266-4016
jparry@greenoughagency.com

Thermo Fisher


Release Versions

Contacts

Media:
Alex Runner
Thermo Fisher Scientific
alex.runner@thermofisher.com

Jessika Parry, Greenough
419-266-4016
jparry@greenoughagency.com

More News From Thermo Fisher

Thermo Fisher Scientific Introduces New Molecular Microscope® Diagnostic System to Aid in Evaluation of Lung Transplant Rejection

WEST HILLS, Calif.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, has introduced a new laboratory developed test for post-transplant biopsy assessment designed to improve the detection of lung transplant rejection and injury, delivering quantifiable results that may increase diagnostic confidence and guide timely treatment. Due to the significant risk of rejection, lung transplant recipients often require routine biopsies to monitor the health of their new lung...

Thermo Fisher Scientific Launches CTS Detachable Dynabeads CD4 and CTS Detachable Dynabeads CD8 to Enhance Cell Therapy Development and Production

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today unveiled the Gibco™ CTS™ Detachable Dynabeads™ CD4 and CTS Detachable Dynabeads CD8 (CTS Detachable Dynabeads)*. These latest products expand on Thermo Fisher’s CTS Detachable Dynabeads platform, which represents a new generation of cell therapy isolation and/or activation products that prioritize cell quality while also creating greater workflow control. Ultimately, these products can hel...

Thermo Fisher Scientific Opens New GMP-certified Ultra-cold Facility in the EU to Accelerate Advanced Therapies Development

BLEISWIJK, Netherlands--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, has opened a new clinical and commercial ultra-cold facility in the EU, expanding its clinical trial network in Europe to help accelerate the development of advanced therapies. The new current good manufacturing practice (cGMP) facility in Bleiswijk, Netherlands provides pharma and biopharma customers tailored, end-to-end support throughout the clinical supply chain for high-value therap...
Back to Newsroom